The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
The tab is the result of a preliminary landscape of vaccines licensed or under development for Mpox
This document provides a list of Paramyxovirus vaccines and therapeutics licensed or under development for pathogens being considered as PRIORITY PATHOGENS.
This document provides a list of vaccines and therapeutics licensed or under development for pathogens being considered as PRIORITY PATHOGENS.
Publications
All →This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...
There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial.
Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...